SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing intense market volatility and negative sentiment as investors express frustration over a prolonged price decline and the potential scaling back of founder Charles Hoskinson's involvement. While some community members are calling the current price action a 'dead' project and a scam, others interpret the heavy selling as a classic capitulation phase and an opportunity for contrarian accumulation.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's stock is drawing intense interest following robust late-stage data for retatrutide, which demonstrates significant weight loss efficacy and reinforces the company's competitive position in the obesity and metabolic health landscape. Community discourse remains heavily focused on the company's pipeline execution, ongoing market share dynamics, and the broader institutional rotation into defensive, high-quality healthcare names amidst broader market volatility.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is capturing significant community attention as investors debate its long-term utility versus its recent market underperformance compared to other assets. While some enthusiasts view current price levels as a generational accumulation opportunity driven by technical indicators and potential regulatory catalysts, others express frustration with its perceived lack of momentum during broader market rallies.

Cal-Maine Foods, Inc. engages in the production, grading, packing, marketing, and distribution of shell eggs. It operates farms, processing plants, hatcheries, feed mills, warehouses, offices and other properties. It markets shell eggs to national and regional grocery store chains, club stores, foodservice distributors, and egg product manufacturers. The company was founded by Fred R. Adams Jr. in 1957 and is headquartered in Ridgeland, MS.

Cal-Maine Foods, Inc.

Cal-Maine Foods is attracting significant attention as investors monitor ongoing egg price volatility and potential regulatory scrutiny from the Department of Justice. The community remains divided, with some highlighting the company's strong balance sheet and dividend potential as a value play, while others express caution regarding the sustainability of current earnings in a shifting supply environment.

ProShares Trust - ProShares UltraPro Short S&P 500

ProShares UltraPro Short S&P 500 ETF

The SPXU is currently trending as traders aggressively debate the market's sustainability at all-time highs, with many using the ETF to hedge against potential volatility and recession risks linked to trade policy and geopolitical instability. Community sentiment remains polarized between contrarian bears seeking to profit from anticipated pullbacks and those warning against the risks of timing market corrections during a prolonged bull trend.

Direxion Shares ETF Trust - Direxion Small Cap Bull 3X ETF

Direxion Daily Small Cap Bull 3X Shares

The Direxion Daily Small Cap Bull 3X Shares (TNA) is trending as investors aggressively position for potential Federal Reserve rate cuts, which are widely expected to act as a significant tailwind for the Russell 2000 small-cap index. The community remains highly active in debating the timing of these cuts, with many traders using TNA as a leveraged vehicle to capitalize on predicted rallies in the small-cap sector while closely monitoring key technical support and resistance levels.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is capturing investor attention as a key infrastructure play within the AI data center power cycle, with strong community interest surrounding the 800V transition and its strategic role in Nvidia's high-efficiency power architecture. Traders are actively discussing the stock's momentum, monitoring technical pullback levels like the 9EMA for entry, while closely watching for potential leadership in the power semiconductor and industrial infrastructure space.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing significant market interest driven by anticipation of multiple upcoming Phase 3 clinical trial readouts for its lead drug candidate, DT-120. Community discussions are highly polarized between investors optimistic about the stock's potential for a sharp re-rate following clinical success and skeptics who are raising concerns about cash burn, management's history of dilution, and the long-term scalability of their psychedelic treatment model.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is currently seeing high volatility as investors react to a mix of speculative narratives regarding a potential SpaceX-Tesla merger and ongoing debates over Tesla's production output and AI roadmap. The community remains deeply divided, with many traders using the leveraged ETF for short-term swings while others debate whether the current price action reflects genuine fundamental value or algorithmic manipulation.

Direxion Shares ETF Trust - Direxion Daily TSLA Bear 1X ETF

Direxion Daily TSLA Bear 1X Shares

TSLS is trending as traders utilize the bear ETF to hedge against volatility and capture downside potential, while the community remains heavily focused on technical levels and the company's long-term competitive standing in the EV market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LivaNova Appoints Anne Liddy as Chief Legal Officer

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the appointment of Anne Liddy as Chief Legal Officer, effective August 31. Liddy will oversee the Companys global legal and compliance function and serve as a member of the Executive Leadership Team. Liddy...

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

NeuroPace exits DIXI, doubles down on RNS as Q1 narrows losses and lifts 2026 guidance, Medicare and pricing actions support margins.

NPCE Explains How NeuroPace's RNS System Makes Money

NeuroPace tightens focus on its RNS epilepsy implant, exits DIXI distribution and pushes AI + cloud workflow tools as 2026 revenue guidance rises.

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

NPCE bets on AI ECoG Assistant and cloud upgrades as it refocuses on RNS, while IGE label review and coverage timing loom.

LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Stefano Folli will join the Company as incoming President, Cardiopulmonary (CP), effective June 1, succeeding Franco Poletti, who will retire on July 31. Folli will partner closely with Poletti over the...

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, Fla. Vladimir...

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LivaNova Q1 Earnings Call Highlights

LivaNova (NASDAQ:LIVN) reported first-quarter 2026 results that management said reflected "durable performance" across its cardiopulmonary and epilepsy businesses, while also highlighting recent regulatory and clinical milestones that it believes position the company for entry into the obstructive s...

LivaNova (LIVN) Q2 2025 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of +15.29% and +3.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.09	--	--	N/A
Q1 '26	$0.97	$0.98	0.94%	BEAT
Q4 '25	$0.82	$0.86	5.29%	BEAT
Q3 '25	$0.92	$1.11	20.81%	BEAT
Q2 '25	$0.87	$1.05	21.06%	BEAT

LIVNLivaNova PLC

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest LIVN News